COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration.

ABSTRACT:

Background

Patients on kidney replacement therapy comprise a vulnerable population and may be at increased risk of death from coronavirus disease 2019 (COVID-19). Currently, only limited data are available on outcomes in this patient population.

Methods

We set up the ERACODA (European Renal Association COVID-19 Database) database, which is specifically designed to prospectively collect detailed data on kidney transplant and dialysis patients with COVID-19. For this analysis, patients were included who presented between 1 February and 1 May 2020 and had complete information available on the primary outcome parameter, 28-day mortality.

Results

Of the 1073 patients enrolled, 305 (28%) were kidney transplant and 768 (72%) dialysis patients with a mean age of 60 ± 13 and 6

SUBMITTER: Hilbrands LB 

PROVIDER: S-EPMC7665620 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature